We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MetLife (MET) Q3 Earnings Beat Estimates on Strong Volume Growth
Read MoreHide Full Article
MetLife, Inc. (MET - Free Report) reported third-quarter 2022 adjusted operating earnings of $1.21 per share, which outpaced the Zacks Consensus Estimate of $1.18. However, the bottom line declined 49% year over year.
Adjusted operating revenues of MetLife amounted to $23,690 million, which increased from $17,087 million in the year-ago quarter. The top line surpassed the consensus mark by 19.1%.
The better-than-expected third-quarter results were driven by volume growth across segments, solid contributions from the Latin America segment and increased interest rates aiding core spreads. However, the upside was partly offset by reduced private equity returns and increased expenses.
Adjusted premiums, fees and other revenues, excluding pension risk transfer (PRT), were $11,061 million, down 3% year over year. Adjusted net investment income fell 27% year over year to $4,163 million in the quarter under review, primarily due to reduced variable investment income stemming from decreased private equity returns.
Total expenses of $21,851 million increased from $14,863 million a year ago, due to higher policyholder benefits and claims. The adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT, increased 140 basis points (bps) year over year to 20.1%.
Net income plunged 78% year over year to $331 million due to derivative and investment losses. Adjusted return on equity, excluding AOCI other than FCTA, deteriorated 810 bps year over year to 8.9%.
Segmental Performances
U.S.: The segment reported adjusted earnings of $744 million, which declined 17% year over year in the third quarter due to reduced variable investment income. However, it beat the Zacks Consensus Estimate of $719.8 million on lower COVID-19 life insurance claims. Adjusted premiums, fees and other revenues, excluding PRT of $6,500 million, climbed 1% year over year.
Asia: Adjusted earnings in the segment amounted to $197 million, which fell 65% year over year in the quarter under review and missed the consensus mark of $418.4 million, due to reduced variable investment income and unfavorable underwriting. This was partially offset by volume growth. Adjusted premiums, fees & other revenues declined 14% year over year to $1,789 million in the third quarter.
Latin America: Adjusted earnings of $171 million increased significantly from $29 million a year ago and beat the Zacks Consensus Estimate of $150.5 million, due to lower claims regarding COVID-19, volume growth and increased interest margins stemming from the inflation in Chile. Adjusted premiums, fees & other revenues advanced 14% or 21% on a cc basis year over year to $1,123 million in the segment, due to growing sales.
EMEA: The segment’s adjusted earnings were $60 million, which plunged 36% year over year in the third quarter, but beat the consensus mark of $59 million. At cc, adjusted earnings fell 20% year over year due to less favorable underwriting. Adjusted premiums, fees & other revenues of $545 million declined 19% year over year. On a cc basis, the same slid 7% year over year due to refinements in some unearned revenue reserves.
MetLife Holdings: Adjusted earnings in the segment slumped 90% year over year to $59 million due to decreased variable investment income. The reported figure also missed the Zacks Consensus Estimate of $269.4 million. Adjusted premiums, fees & other revenues fell 11% year over year to $1,016 million in the quarter under review.
Corporate & Other: Adjusted loss of $265 million widened from the prior-year quarter’s loss of $131 million.
Financial Update (as of Sep 30, 2022)
MetLife exited the third quarter with cash and cash equivalents of $22,200 million, which increased from $20,047 million at 2021-end. Total assets of $650.1 billion declined from $759.7 billion in fourth-quarter 2021 end.
Long-term debt totaled $14,520 million, up from $13,933 million at 2021-end. It also had a short-term debt of $183 million. Total equity of $25,330 million decreased from $67,749 million at 2021-end.
Capital Deployment Update
MetLife bought back shares worth $674 million during the third quarter.
Headquartered in Bloomfield, CT, Cigna is a major health service company. The Zacks Consensus Estimate for CI’s 2022 bottom line indicates 12.4% year-over-year growth.
New York-based StoneX Group works as a global financial services network. The Zacks Consensus Estimate for SNEX’s 2022 bottom line indicates 54.8% year-over-year growth.
Based in Boca Raton, FL, FlexShopper is a leading e-commerce marketplace operator. The Zacks Consensus Estimate for FPAY’s 2022 earnings is pegged at 70 cents per share, signaling a massive jump from the 4 cents reported a year ago.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
MetLife (MET) Q3 Earnings Beat Estimates on Strong Volume Growth
MetLife, Inc. (MET - Free Report) reported third-quarter 2022 adjusted operating earnings of $1.21 per share, which outpaced the Zacks Consensus Estimate of $1.18. However, the bottom line declined 49% year over year.
Adjusted operating revenues of MetLife amounted to $23,690 million, which increased from $17,087 million in the year-ago quarter. The top line surpassed the consensus mark by 19.1%.
The better-than-expected third-quarter results were driven by volume growth across segments, solid contributions from the Latin America segment and increased interest rates aiding core spreads. However, the upside was partly offset by reduced private equity returns and increased expenses.
MetLife, Inc. Price, Consensus and EPS Surprise
MetLife, Inc. price-consensus-eps-surprise-chart | MetLife, Inc. Quote
Behind the Headlines
Adjusted premiums, fees and other revenues, excluding pension risk transfer (PRT), were $11,061 million, down 3% year over year. Adjusted net investment income fell 27% year over year to $4,163 million in the quarter under review, primarily due to reduced variable investment income stemming from decreased private equity returns.
Total expenses of $21,851 million increased from $14,863 million a year ago, due to higher policyholder benefits and claims. The adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT, increased 140 basis points (bps) year over year to 20.1%.
Net income plunged 78% year over year to $331 million due to derivative and investment losses. Adjusted return on equity, excluding AOCI other than FCTA, deteriorated 810 bps year over year to 8.9%.
Segmental Performances
U.S.: The segment reported adjusted earnings of $744 million, which declined 17% year over year in the third quarter due to reduced variable investment income. However, it beat the Zacks Consensus Estimate of $719.8 million on lower COVID-19 life insurance claims. Adjusted premiums, fees and other revenues, excluding PRT of $6,500 million, climbed 1% year over year.
Asia: Adjusted earnings in the segment amounted to $197 million, which fell 65% year over year in the quarter under review and missed the consensus mark of $418.4 million, due to reduced variable investment income and unfavorable underwriting. This was partially offset by volume growth. Adjusted premiums, fees & other revenues declined 14% year over year to $1,789 million in the third quarter.
Latin America: Adjusted earnings of $171 million increased significantly from $29 million a year ago and beat the Zacks Consensus Estimate of $150.5 million, due to lower claims regarding COVID-19, volume growth and increased interest margins stemming from the inflation in Chile. Adjusted premiums, fees & other revenues advanced 14% or 21% on a cc basis year over year to $1,123 million in the segment, due to growing sales.
EMEA: The segment’s adjusted earnings were $60 million, which plunged 36% year over year in the third quarter, but beat the consensus mark of $59 million. At cc, adjusted earnings fell 20% year over year due to less favorable underwriting. Adjusted premiums, fees & other revenues of $545 million declined 19% year over year. On a cc basis, the same slid 7% year over year due to refinements in some unearned revenue reserves.
MetLife Holdings: Adjusted earnings in the segment slumped 90% year over year to $59 million due to decreased variable investment income. The reported figure also missed the Zacks Consensus Estimate of $269.4 million. Adjusted premiums, fees & other revenues fell 11% year over year to $1,016 million in the quarter under review.
Corporate & Other: Adjusted loss of $265 million widened from the prior-year quarter’s loss of $131 million.
Financial Update (as of Sep 30, 2022)
MetLife exited the third quarter with cash and cash equivalents of $22,200 million, which increased from $20,047 million at 2021-end. Total assets of $650.1 billion declined from $759.7 billion in fourth-quarter 2021 end.
Long-term debt totaled $14,520 million, up from $13,933 million at 2021-end. It also had a short-term debt of $183 million. Total equity of $25,330 million decreased from $67,749 million at 2021-end.
Capital Deployment Update
MetLife bought back shares worth $674 million during the third quarter.
Zacks Rank & Key Picks
MetLife currently has a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader finance space are Cigna Corporation (CI - Free Report) , StoneX Group Inc. (SNEX - Free Report) and FlexShopper, Inc. (FPAY - Free Report) , each having a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Headquartered in Bloomfield, CT, Cigna is a major health service company. The Zacks Consensus Estimate for CI’s 2022 bottom line indicates 12.4% year-over-year growth.
New York-based StoneX Group works as a global financial services network. The Zacks Consensus Estimate for SNEX’s 2022 bottom line indicates 54.8% year-over-year growth.
Based in Boca Raton, FL, FlexShopper is a leading e-commerce marketplace operator. The Zacks Consensus Estimate for FPAY’s 2022 earnings is pegged at 70 cents per share, signaling a massive jump from the 4 cents reported a year ago.